ESMO, the leading European professional organisation for medical oncology, has launched a new award to honour cancer immunotherapy innovators.
The ESMO Award for Immuno-Oncology is in memory of Professor Georges Mathé, a French oncologist and immunologist who performed the first bone marrow graft between unrelated donors in 1958.
The first award will be presented at the ESMO Immuno-Oncology Congress in Geneva on 7 December 2017.
ESMO President Fortunato Ciardiello said: 'Immunotherapy is an exciting and rapidly evolving area in oncology. Recognising excellence in this emerging area is a duty and an honour for us, as the society of reference committed to improving outcomes for cancer patients.'
Professor Mathé worked in immunotherapy from the 1950s to the 1980s, and its emergence has changed the landscape of treatment options, ESMO says.
Catherine Gaston-Mathé , Professor Mathé’s daughter, said she was proud that her father’s achievements were being honoured through the award.
'As the descendant of one of ESMO’s founders and immunotherapy pioneers, I am grateful for the appreciation of his work which has brought new hope for cancer patients,' she added.
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.